Search

Literature Lessons

By Ted Rosen, MD, FAAD, Editor-in-Chief ATOPIC DERMATITIS When compared to other agents used for atopic dermatitis severe enough to warrant systemic therapy (methotrexate, cyclosporine, and mycophenolate), DUMILUMAB was associated with an increased relative risk of conjunctivitis but lowered relative risk for serious infection. TO READ MORE: Schneeweiss MC. Dupilumab and the risk of conjunctivitis […]